• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

红斑狼疮的创新管理。

Innovative management of lupus erythematosus.

机构信息

Department of Dermatology, Cleveland Clinic, 9500 Euclid Avenue, A-61, Cleveland, OH 44195, USA.

出版信息

Dermatol Clin. 2010 Jul;28(3):489-99. doi: 10.1016/j.det.2010.03.007.

DOI:10.1016/j.det.2010.03.007
PMID:20510759
Abstract

This article focuses on the management of discoid lupus erythematosus, subacute cutaneous lupus erythematosus, and systemic lupus erythematosus when the usual therapeutic arsenal such as oral antimalarial drugs and topical/oral steroids fail or provide insufficient treatment efficacy. Many of the treatments listed are the same or similar to each other because of similarities in the pathogenesis of various subtypes of cutaneous lupus. The clinical challenge is to determine the indications for topical versus systemic therapy, and to also identify the scenarios when combined therapy is necessary.

摘要

本文重点介绍盘状红斑狼疮、亚急性皮肤型红斑狼疮和全身性红斑狼疮的治疗管理,当常规治疗方法(如口服抗疟药物和局部/口服类固醇)无效或疗效不足时。列出的许多治疗方法彼此相似,因为各种皮肤型红斑狼疮的发病机制相似。临床挑战在于确定局部治疗与系统治疗的适应证,以及确定何时需要联合治疗。

相似文献

1
Innovative management of lupus erythematosus.红斑狼疮的创新管理。
Dermatol Clin. 2010 Jul;28(3):489-99. doi: 10.1016/j.det.2010.03.007.
2
Pimecrolimus 1% cream for cutaneous lupus erythematosus.用于皮肤型红斑狼疮的1%吡美莫司乳膏。
J Am Acad Dermatol. 2004 Sep;51(3):407-10. doi: 10.1016/j.jaad.2004.01.044.
3
Cutaneous lupus erythematosus: issues in diagnosis and treatment.皮肤红斑狼疮:诊断与治疗中的问题
Am J Clin Dermatol. 2009;10(6):365-81. doi: 10.2165/11310780-000000000-00000.
4
Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.外用他克莫司治疗红斑狼疮耐药性皮肤损害:一种可能的替代方法。
Rheumatology (Oxford). 2004 Nov;43(11):1383-5. doi: 10.1093/rheumatology/keh325. Epub 2004 Jul 20.
5
The different faces of cutaneous lupus erythematosus.皮肤红斑狼疮的不同表现
G Ital Dermatol Venereol. 2009 Apr;144(2):135-47.
6
Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment.患有皮肤红斑狼疮的吸烟者对抗疟治疗的反应较差。
J Am Acad Dermatol. 2000 Jun;42(6):983-7.
7
Management of "refractory" skin disease in patients with lupus erythematosus.红斑狼疮患者中“难治性”皮肤病的管理。
Best Pract Res Clin Rheumatol. 2005 Oct;19(5):767-84. doi: 10.1016/j.berh.2005.05.003.
8
Treatment of cutaneous lesions in patients with lupus erythematosus.红斑狼疮患者皮肤损害的治疗。
Dermatol Clin. 1994 Jan;12(1):201-6.
9
Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.米帕林与羟氯喹联合治疗系统性红斑狼疮伴难治性皮肤和关节活动患者。
Lupus. 2018 Sep;27(10):1718-1722. doi: 10.1177/0961203318768877. Epub 2018 Apr 10.
10
Successful treatment of generalized discoid skin lesions with azathioprine. Its use in a patient with systemic lupus erythematosus.硫唑嘌呤成功治疗泛发性盘状皮肤损害。其在一名系统性红斑狼疮患者中的应用。
Arch Dermatol. 1985 Oct;121(10):1323-5.

引用本文的文献

1
Efficacy and safety of calcineurin inhibitors in cutaneous lupus: a systematic review and brief meta-analysis of recommended concentration, type, and outcomes.钙调神经磷酸酶抑制剂治疗皮肤型红斑狼疮的疗效与安全性:关于推荐浓度、类型及结局的系统评价与简要荟萃分析
Ann Med Surg (Lond). 2025 Mar 3;87(5):2880-2888. doi: 10.1097/MS9.0000000000003047. eCollection 2025 May.
2
Azathioprine: its uses in dermatology.硫唑嘌呤:其在皮肤科的应用。
An Bras Dermatol. 2020 Nov-Dec;95(6):731-736. doi: 10.1016/j.abd.2020.05.003. Epub 2020 Sep 11.
3
Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects.
治疗皮肤红斑狼疮的选择:最新进展和未来前景。
Expert Rev Clin Immunol. 2016 Oct;12(10):1109-21. doi: 10.1080/1744666X.2016.1188006. Epub 2016 Jun 1.
4
[Current "off label use" of methotrexate for chronic inflammatory rheumatic diseases].[甲氨蝶呤目前在慢性炎症性风湿性疾病中的“超说明书用药”情况]
Z Rheumatol. 2011 Feb;70(2):123-8. doi: 10.1007/s00393-010-0685-2.